Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Biological Drugs Market Growth 2022-2028

  • LP 4791256
  • 103 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Biological Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Biological Drugs market size is USD million in 2022 from USD 277550 million in 2021, with a change of % between 2021 and 2022. The global Biological Drugs market size will reach USD 491510 million in 2028, growing at a CAGR of 8.5% over the analysis period.

The United States Biological Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Biological Drugs market, reaching US$ million by the year 2028. As for the Europe Biological Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Biological Drugs players cover Bristol-Myers Squibb, Eli Lilly, Takeda, and Pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Biological Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Therapeutic Protein

Monoclonal Antibody

Vaccine

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospitals

Ambulatory Surgical Centers

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Bristol-Myers Squibb

Eli Lilly

Takeda

Pfizer

Amgen

F. Hoffmann-La Roche

Johnson & Johnson

Merck

Abbott Laboratories

Baxter

Novartis

Biogen

GlaxoSmithKline

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Biological Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Biological Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Biological Drugs by Country/Region, 2017, 2022 & 2028

2.2 Biological Drugs Segment by Type

2.2.1 Therapeutic Protein

2.2.2 Monoclonal Antibody

2.2.3 Vaccine

2.2.4 Others

2.3 Biological Drugs Sales by Type

2.3.1 Global Biological Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Biological Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Biological Drugs Sale Price by Type (2017-2022)

2.4 Biological Drugs Segment by Application

2.4.1 Hospitals

2.4.2 Ambulatory Surgical Centers

2.4.3 Others

2.5 Biological Drugs Sales by Application

2.5.1 Global Biological Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Biological Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Biological Drugs Sale Price by Application (2017-2022)

3 Global Biological Drugs by Company

3.1 Global Biological Drugs Breakdown Data by Company

3.1.1 Global Biological Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Biological Drugs Sales Market Share by Company (2020-2022)

3.2 Global Biological Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Biological Drugs Revenue by Company (2020-2022)

3.2.2 Global Biological Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Biological Drugs Sale Price by Company

3.4 Key Manufacturers Biological Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Biological Drugs Product Location Distribution

3.4.2 Players Biological Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Biological Drugs by Geographic Region

4.1 World Historic Biological Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Biological Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Biological Drugs Annual Revenue by Geographic Region

4.2 World Historic Biological Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Biological Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Biological Drugs Annual Revenue by Country/Region

4.3 Americas Biological Drugs Sales Growth

4.4 APAC Biological Drugs Sales Growth

4.5 Europe Biological Drugs Sales Growth

4.6 Middle East & Africa Biological Drugs Sales Growth

5 Americas

5.1 Americas Biological Drugs Sales by Country

5.1.1 Americas Biological Drugs Sales by Country (2017-2022)

5.1.2 Americas Biological Drugs Revenue by Country (2017-2022)

5.2 Americas Biological Drugs Sales by Type

5.3 Americas Biological Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Biological Drugs Sales by Region

6.1.1 APAC Biological Drugs Sales by Region (2017-2022)

6.1.2 APAC Biological Drugs Revenue by Region (2017-2022)

6.2 APAC Biological Drugs Sales by Type

6.3 APAC Biological Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Biological Drugs by Country

7.1.1 Europe Biological Drugs Sales by Country (2017-2022)

7.1.2 Europe Biological Drugs Revenue by Country (2017-2022)

7.2 Europe Biological Drugs Sales by Type

7.3 Europe Biological Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Biological Drugs by Country

8.1.1 Middle East & Africa Biological Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Biological Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Biological Drugs Sales by Type

8.3 Middle East & Africa Biological Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Biological Drugs

10.3 Manufacturing Process Analysis of Biological Drugs

10.4 Industry Chain Structure of Biological Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Biological Drugs Distributors

11.3 Biological Drugs Customer

12 World Forecast Review for Biological Drugs by Geographic Region

12.1 Global Biological Drugs Market Size Forecast by Region

12.1.1 Global Biological Drugs Forecast by Region (2023-2028)

12.1.2 Global Biological Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Biological Drugs Forecast by Type

12.7 Global Biological Drugs Forecast by Application

13 Key Players Analysis

13.1 Bristol-Myers Squibb

13.1.1 Bristol-Myers Squibb Company Information

13.1.2 Bristol-Myers Squibb Biological Drugs Product Offered

13.1.3 Bristol-Myers Squibb Biological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bristol-Myers Squibb Main Business Overview

13.1.5 Bristol-Myers Squibb Latest Developments

13.2 Eli Lilly

13.2.1 Eli Lilly Company Information

13.2.2 Eli Lilly Biological Drugs Product Offered

13.2.3 Eli Lilly Biological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Eli Lilly Main Business Overview

13.2.5 Eli Lilly Latest Developments

13.3 Takeda

13.3.1 Takeda Company Information

13.3.2 Takeda Biological Drugs Product Offered

13.3.3 Takeda Biological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Takeda Main Business Overview

13.3.5 Takeda Latest Developments

13.4 Pfizer

13.4.1 Pfizer Company Information

13.4.2 Pfizer Biological Drugs Product Offered

13.4.3 Pfizer Biological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Pfizer Main Business Overview

13.4.5 Pfizer Latest Developments

13.5 Amgen

13.5.1 Amgen Company Information

13.5.2 Amgen Biological Drugs Product Offered

13.5.3 Amgen Biological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Amgen Main Business Overview

13.5.5 Amgen Latest Developments

13.6 F. Hoffmann-La Roche

13.6.1 F. Hoffmann-La Roche Company Information

13.6.2 F. Hoffmann-La Roche Biological Drugs Product Offered

13.6.3 F. Hoffmann-La Roche Biological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 F. Hoffmann-La Roche Main Business Overview

13.6.5 F. Hoffmann-La Roche Latest Developments

13.7 Johnson & Johnson

13.7.1 Johnson & Johnson Company Information

13.7.2 Johnson & Johnson Biological Drugs Product Offered

13.7.3 Johnson & Johnson Biological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Johnson & Johnson Main Business Overview

13.7.5 Johnson & Johnson Latest Developments

13.8 Merck

13.8.1 Merck Company Information

13.8.2 Merck Biological Drugs Product Offered

13.8.3 Merck Biological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Merck Main Business Overview

13.8.5 Merck Latest Developments

13.9 Abbott Laboratories

13.9.1 Abbott Laboratories Company Information

13.9.2 Abbott Laboratories Biological Drugs Product Offered

13.9.3 Abbott Laboratories Biological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Abbott Laboratories Main Business Overview

13.9.5 Abbott Laboratories Latest Developments

13.10 Baxter

13.10.1 Baxter Company Information

13.10.2 Baxter Biological Drugs Product Offered

13.10.3 Baxter Biological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Baxter Main Business Overview

13.10.5 Baxter Latest Developments

13.11 Novartis

13.11.1 Novartis Company Information

13.11.2 Novartis Biological Drugs Product Offered

13.11.3 Novartis Biological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Novartis Main Business Overview

13.11.5 Novartis Latest Developments

13.12 Biogen

13.12.1 Biogen Company Information

13.12.2 Biogen Biological Drugs Product Offered

13.12.3 Biogen Biological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Biogen Main Business Overview

13.12.5 Biogen Latest Developments

13.13 GlaxoSmithKline

13.13.1 GlaxoSmithKline Company Information

13.13.2 GlaxoSmithKline Biological Drugs Product Offered

13.13.3 GlaxoSmithKline Biological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 GlaxoSmithKline Main Business Overview

13.13.5 GlaxoSmithKline Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Biological Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Biological Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Therapeutic Protein

Table 4. Major Players of Monoclonal Antibody

Table 5. Major Players of Vaccine

Table 6. Major Players of Others

Table 7. Global Biological Drugs Sales by Type (2017-2022) & (K MT)

Table 8. Global Biological Drugs Sales Market Share by Type (2017-2022)

Table 9. Global Biological Drugs Revenue by Type (2017-2022) & ($ million)

Table 10. Global Biological Drugs Revenue Market Share by Type (2017-2022)

Table 11. Global Biological Drugs Sale Price by Type (2017-2022) & (USD/MT)

Table 12. Global Biological Drugs Sales by Application (2017-2022) & (K MT)

Table 13. Global Biological Drugs Sales Market Share by Application (2017-2022)

Table 14. Global Biological Drugs Revenue by Application (2017-2022)

Table 15. Global Biological Drugs Revenue Market Share by Application (2017-2022)

Table 16. Global Biological Drugs Sale Price by Application (2017-2022) & (USD/MT)

Table 17. Global Biological Drugs Sales by Company (2020-2022) & (K MT)

Table 18. Global Biological Drugs Sales Market Share by Company (2020-2022)

Table 19. Global Biological Drugs Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Biological Drugs Revenue Market Share by Company (2020-2022)

Table 21. Global Biological Drugs Sale Price by Company (2020-2022) & (USD/MT)

Table 22. Key Manufacturers Biological Drugs Producing Area Distribution and Sales Area

Table 23. Players Biological Drugs Products Offered

Table 24. Biological Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Biological Drugs Sales by Geographic Region (2017-2022) & (K MT)

Table 28. Global Biological Drugs Sales Market Share Geographic Region (2017-2022)

Table 29. Global Biological Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Biological Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Biological Drugs Sales by Country/Region (2017-2022) & (K MT)

Table 32. Global Biological Drugs Sales Market Share by Country/Region (2017-2022)

Table 33. Global Biological Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Biological Drugs Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Biological Drugs Sales by Country (2017-2022) & (K MT)

Table 36. Americas Biological Drugs Sales Market Share by Country (2017-2022)

Table 37. Americas Biological Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Biological Drugs Revenue Market Share by Country (2017-2022)

Table 39. Americas Biological Drugs Sales by Type (2017-2022) & (K MT)

Table 40. Americas Biological Drugs Sales Market Share by Type (2017-2022)

Table 41. Americas Biological Drugs Sales by Application (2017-2022) & (K MT)

Table 42. Americas Biological Drugs Sales Market Share by Application (2017-2022)

Table 43. APAC Biological Drugs Sales by Region (2017-2022) & (K MT)

Table 44. APAC Biological Drugs Sales Market Share by Region (2017-2022)

Table 45. APAC Biological Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Biological Drugs Revenue Market Share by Region (2017-2022)

Table 47. APAC Biological Drugs Sales by Type (2017-2022) & (K MT)

Table 48. APAC Biological Drugs Sales Market Share by Type (2017-2022)

Table 49. APAC Biological Drugs Sales by Application (2017-2022) & (K MT)

Table 50. APAC Biological Drugs Sales Market Share by Application (2017-2022)

Table 51. Europe Biological Drugs Sales by Country (2017-2022) & (K MT)

Table 52. Europe Biological Drugs Sales Market Share by Country (2017-2022)

Table 53. Europe Biological Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Biological Drugs Revenue Market Share by Country (2017-2022)

Table 55. Europe Biological Drugs Sales by Type (2017-2022) & (K MT)

Table 56. Europe Biological Drugs Sales Market Share by Type (2017-2022)

Table 57. Europe Biological Drugs Sales by Application (2017-2022) & (K MT)

Table 58. Europe Biological Drugs Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Biological Drugs Sales by Country (2017-2022) & (K MT)

Table 60. Middle East & Africa Biological Drugs Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Biological Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Biological Drugs Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Biological Drugs Sales by Type (2017-2022) & (K MT)

Table 64. Middle East & Africa Biological Drugs Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Biological Drugs Sales by Application (2017-2022) & (K MT)

Table 66. Middle East & Africa Biological Drugs Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Biological Drugs

Table 68. Key Market Challenges & Risks of Biological Drugs

Table 69. Key Industry Trends of Biological Drugs

Table 70. Biological Drugs Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Biological Drugs Distributors List

Table 73. Biological Drugs Customer List

Table 74. Global Biological Drugs Sales Forecast by Region (2023-2028) & (K MT)

Table 75. Global Biological Drugs Sales Market Forecast by Region

Table 76. Global Biological Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Biological Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Biological Drugs Sales Forecast by Country (2023-2028) & (K MT)

Table 79. Americas Biological Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Biological Drugs Sales Forecast by Region (2023-2028) & (K MT)

Table 81. APAC Biological Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Biological Drugs Sales Forecast by Country (2023-2028) & (K MT)

Table 83. Europe Biological Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Biological Drugs Sales Forecast by Country (2023-2028) & (K MT)

Table 85. Middle East & Africa Biological Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Biological Drugs Sales Forecast by Type (2023-2028) & (K MT)

Table 87. Global Biological Drugs Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Biological Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Biological Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Biological Drugs Sales Forecast by Application (2023-2028) & (K MT)

Table 91. Global Biological Drugs Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Biological Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Biological Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 94. Bristol-Myers Squibb Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors

Table 95. Bristol-Myers Squibb Biological Drugs Product Offered

Table 96. Bristol-Myers Squibb Biological Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 97. Bristol-Myers Squibb Main Business

Table 98. Bristol-Myers Squibb Latest Developments

Table 99. Eli Lilly Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors

Table 100. Eli Lilly Biological Drugs Product Offered

Table 101. Eli Lilly Biological Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 102. Eli Lilly Main Business

Table 103. Eli Lilly Latest Developments

Table 104. Takeda Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors

Table 105. Takeda Biological Drugs Product Offered

Table 106. Takeda Biological Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 107. Takeda Main Business

Table 108. Takeda Latest Developments

Table 109. Pfizer Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors

Table 110. Pfizer Biological Drugs Product Offered

Table 111. Pfizer Biological Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 112. Pfizer Main Business

Table 113. Pfizer Latest Developments

Table 114. Amgen Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors

Table 115. Amgen Biological Drugs Product Offered

Table 116. Amgen Biological Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 117. Amgen Main Business

Table 118. Amgen Latest Developments

Table 119. F. Hoffmann-La Roche Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors

Table 120. F. Hoffmann-La Roche Biological Drugs Product Offered

Table 121. F. Hoffmann-La Roche Biological Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 122. F. Hoffmann-La Roche Main Business

Table 123. F. Hoffmann-La Roche Latest Developments

Table 124. Johnson & Johnson Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors

Table 125. Johnson & Johnson Biological Drugs Product Offered

Table 126. Johnson & Johnson Biological Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 127. Johnson & Johnson Main Business

Table 128. Johnson & Johnson Latest Developments

Table 129. Merck Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors

Table 130. Merck Biological Drugs Product Offered

Table 131. Merck Biological Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 132. Merck Main Business

Table 133. Merck Latest Developments

Table 134. Abbott Laboratories Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors

Table 135. Abbott Laboratories Biological Drugs Product Offered

Table 136. Abbott Laboratories Biological Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 137. Abbott Laboratories Main Business

Table 138. Abbott Laboratories Latest Developments

Table 139. Baxter Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors

Table 140. Baxter Biological Drugs Product Offered

Table 141. Baxter Biological Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 142. Baxter Main Business

Table 143. Baxter Latest Developments

Table 144. Novartis Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors

Table 145. Novartis Biological Drugs Product Offered

Table 146. Novartis Biological Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 147. Novartis Main Business

Table 148. Novartis Latest Developments

Table 149. Biogen Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors

Table 150. Biogen Biological Drugs Product Offered

Table 151. Biogen Biological Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 152. Biogen Main Business

Table 153. Biogen Latest Developments

Table 154. GlaxoSmithKline Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors

Table 155. GlaxoSmithKline Biological Drugs Product Offered

Table 156. GlaxoSmithKline Biological Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 157. GlaxoSmithKline Main Business

Table 158. GlaxoSmithKline Latest Developments

List of Figures

Figure 1. Picture of Biological Drugs

Figure 2. Biological Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Biological Drugs Sales Growth Rate 2017-2028 (K MT)

Figure 7. Global Biological Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Biological Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Therapeutic Protein

Figure 10. Product Picture of Monoclonal Antibody

Figure 11. Product Picture of Vaccine

Figure 12. Product Picture of Others

Figure 13. Global Biological Drugs Sales Market Share by Type in 2021

Figure 14. Global Biological Drugs Revenue Market Share by Type (2017-2022)

Figure 15. Biological Drugs Consumed in Hospitals

Figure 16. Global Biological Drugs Market: Hospitals (2017-2022) & (K MT)

Figure 17. Biological Drugs Consumed in Ambulatory Surgical Centers

Figure 18. Global Biological Drugs Market: Ambulatory Surgical Centers (2017-2022) & (K MT)

Figure 19. Biological Drugs Consumed in Others

Figure 20. Global Biological Drugs Market: Others (2017-2022) & (K MT)

Figure 21. Global Biological Drugs Sales Market Share by Application (2017-2022)

Figure 22. Global Biological Drugs Revenue Market Share by Application in 2021

Figure 23. Biological Drugs Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Biological Drugs Revenue Market Share by Company in 2021

Figure 25. Global Biological Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Biological Drugs Revenue Market Share by Geographic Region in 2021

Figure 27. Global Biological Drugs Sales Market Share by Region (2017-2022)

Figure 28. Global Biological Drugs Revenue Market Share by Country/Region in 2021

Figure 29. Americas Biological Drugs Sales 2017-2022 (K MT)

Figure 30. Americas Biological Drugs Revenue 2017-2022 ($ Millions)

Figure 31. APAC Biological Drugs Sales 2017-2022 (K MT)

Figure 32. APAC Biological Drugs Revenue 2017-2022 ($ Millions)

Figure 33. Europe Biological Drugs Sales 2017-2022 (K MT)

Figure 34. Europe Biological Drugs Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Biological Drugs Sales 2017-2022 (K MT)

Figure 36. Middle East & Africa Biological Drugs Revenue 2017-2022 ($ Millions)

Figure 37. Americas Biological Drugs Sales Market Share by Country in 2021

Figure 38. Americas Biological Drugs Revenue Market Share by Country in 2021

Figure 39. United States Biological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Biological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Biological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Biological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Biological Drugs Sales Market Share by Region in 2021

Figure 44. APAC Biological Drugs Revenue Market Share by Regions in 2021

Figure 45. China Biological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Biological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Biological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Biological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Biological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Biological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Biological Drugs Sales Market Share by Country in 2021

Figure 52. Europe Biological Drugs Revenue Market Share by Country in 2021

Figure 53. Germany Biological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Biological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Biological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Biological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Biological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Biological Drugs Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Biological Drugs Revenue Market Share by Country in 2021

Figure 60. Egypt Biological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Biological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Biological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Biological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Biological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Biological Drugs in 2021

Figure 66. Manufacturing Process Analysis of Biological Drugs

Figure 67. Industry Chain Structure of Biological Drugs

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390